Clinical Trial Update: Systems Biology of PNEUMOVAX®23 and PREVNAR 13® [NA]

View source ↗

Summary

Clinical trial update on systems biology of Pneumovax23 and Prevnar13; completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infection

Drugs mentioned

• Pneumovax 23 (Pneumococcal polysaccharide vaccine 23-valent)
• Prevnar 13 (pneumococcal conjugate vaccine)

Snippet

Sponsor: Emory University | Conditions: Pneumococcal Infection | NA | Status: COMPLETED | Results posted: 2018-10-02